Pharma — India Trademark Cases
240 decisions indexed
Page 2 of 8 · 240 total
Jitesh Kumar S/O Omprakash Maheshwary v.Babushah Ibrahimsha Juneja & Anr.
This appeal before the Gujarat High Court challenged an interim injunction granted by the Trial Court in Trademark Suit No. 1 of 2023. The original plaintiffs sought relief against alleged infringement of their registered copyright and passing-off of their trademark 'RAJ KHUSHBU' concerning Ayurvedic Medicinal Oils. The High Court, while not examining the merits of the underlying dispute, quashed the lower court's order on the grounds that it was non-speaking. Consequently, the injunction application was restored to the Trial Court for a fresh hearing.
Sun Pharmaceutical Laboratories Ltd v.Rspl Helathcare P Ltd & Anr.
The Delhi High Court addressed an appeal challenging a District Judge's order that had granted an ex parte injunction against Sun Pharmaceutical Laboratories Ltd, restraining it from using the trademark 'PRUEASE'. The court set aside this restrictive interim order. Instead, it directed the Trial Court to expedite the hearing of the original application filed by the respondents seeking injunctive relief, allowing both parties a chance to present their case.
Innovative Health Care v.Innovative Healthcare (India) Pvt. Ltd.
The Madras High Court addressed an Original Application filed by Innovative Health Care seeking to restrain Innovative Healthcare (India) Pvt. Ltd. from using a deceptively similar trademark for medicinal preparations. The court decided to close the current application while granting the applicant full liberty to raise all its contentions in the main suit. This procedural step moves the dispute forward into the substantive litigation phase.
Mankind Pharma Limited v.Pranjali Swapnil Pimprikar Trading As A2 Lifesciences & Anr.
Mankind Pharma Limited and Pranjali Swapnil Pimprikar Trading As A2 Lifesciences reached a full settlement regarding trademark disputes concerning the 'ALL OK+' product. The defendant acknowledged Mankind's exclusive rights to its trade dress and agreed not to use any confusingly similar marks. In exchange, the plaintiff dropped claims for damages, allowing the defendant to continue using the mark provided the trade dress was distinct.
Kedar Nath Mishra v.Invision Medi Sciences Pvt. Ltd.
The Delhi High Court deferred the appeals filed by Kedar Nath Mishra against Invision Medi Sciences Pvt. Ltd. The court allowed further time for arguments and noted that the respondent required additional time to place documents on record regarding an amendment to its trademark registration, reflecting usage since 31.12.2007. Consequently, the appeals were released from part-heard status and rescheduled for a later date.
Mankind Pharma Limited v.Alembic Pharmaceuticals Limited
In a trademark infringement suit, Mankind Pharma Limited sought an injunction against Alembic Pharmaceuticals Limited regarding the use of the mark 'TOFASTAR' versus 'TOBASTAR'. The court allowed the plaintiff's request for exemption from pre-litigation mediation due to the urgency of the matter. Furthermore, both parties indicated a willingness to settle the dispute at the earliest opportunity, leading the court to renotify the case for further proceedings.
Mankind Pharma Limited v.Morepen Laboratories Limited
The Delhi High Court addressed several procedural applications in the trademark and copyright infringement suit filed by Mankind Pharma against Morepen Laboratories. The court granted exemptions regarding document filing and pre-institution mediation, while proceeding with the main injunction application (I.A. 38001/2024). The plaintiff alleged dishonest adoption of their registered trade dress and copyright for a pregnancy detection strip, leading to claims of infringement and passing off. The defendant countered by arguing that the plaintiff approached the court belatedly.
Merck Kgaa v.Bharat Patel
Merck Kgaa successfully secured an ex parte ad interim injunction against Bharat Patel in the Delhi High Court. The court found that Merck's trademark 'MERCK' is well-known and granted immediate relief, preventing the defendant from using any confusingly similar marks or names. This ruling underscores the strong protection afforded to established, globally recognized trademarks under Indian law.
Himalaya Global Holdings Ltd & Anr. v.Ms Ab Allcare Herbal & Ors.
The Delhi High Court granted crucial interim relief in the trademark infringement suit filed by Himalaya Global Holdings Ltd against Ms Ab Allcare Herbal & Ors. The court allowed the plaintiffs to proceed with seizing alleged infringing products using Local Commissioners. Furthermore, it permitted the commissioners to inspect defendants' books of accounts and stock registers related to the disputed goods. This order significantly advances the plaintiff's case for permanent injunction regarding the 'Liv.52' trademark and Himalaya's distinctive trade dress.
Sun Pharmaceutical Industries Ltd. v.M/S. Orison Pharmaceuticals
The Delhi High Court addressed a suit filed by Sun Pharmaceutical Industries Ltd. against M/S. Orison Pharmaceuticals concerning alleged trademark infringement and passing off of marks like 'REVITAL' and 'CEROXIM'. Despite the plaintiff alleging deceptive similarity in the defendant's marks ('ORIVITAL' and 'OXIM'), both parties expressed interest in exploring a settlement. Consequently, the Court referred the matter to the Delhi High Court Mediation and Conciliation Centre for resolution.
Pfizer Products Inv. v.Cadila Pharmaceuticals Limited & Anr.
The Gujarat High Court disposed of a Rectification Application filed by Pfizer Products Inv. against Cadila Pharmaceuticals Limited & Anr. The court noted that the respondents had withdrawn their trademark registration application, rendering the original dispute moot and infructuous. Consequently, the application was dismissed.
Dr. Reddys Laboratories Limited v.Zentech Pharmaceuticals And Anr.
The Delhi High Court granted an interim injunction in favor of Dr. Reddys Laboratories Limited against Zentech Pharmaceuticals And Anr. The court found a prima facie case for infringement and passing off, noting that the defendant adopted a phonetically similar trademark (ZEEDUX) and copied the entire trade dress and color scheme of the plaintiff's well-known brand (ZEDEX). This order temporarily restrains the defendants from manufacturing or using the infringing product while the main suit proceeds.
Zuventus Healthcare Limited v.Zaventis Health Care Private Limited
The Delhi High Court granted an interim injunction in favor of Zuventus Healthcare Limited against Zaventis Health Care Private Limited. The court found that the defendant's mark, 'ZAVENTIS HEALTH CARE,' was visually, structurally, and phonetically similar to the plaintiff's registered trademark 'ZUVENTUS,' leading to a prima facie case of infringement and passing off. This order allows the suit to proceed while restraining the defendant from using any deceptively similar branding in relation to pharmaceutical products.
Cipla Health Limited v.Aishwarya Healthcare & Ors.
The Delhi High Court granted an interim injunction in favor of Cipla Health Limited against Aishwarya Healthcare & Ors. The court found a prima facie case for trademark infringement and passing off, noting that the Defendants' mark 'OMNICEL' is virtually identical to the Plaintiff's established mark 'OMNIGEL'. Furthermore, the court recognized the Plaintiff's copyright claim over the product packaging, leading to a comprehensive restraint order against the use of deceptively similar marks and trade dress.
Macleods Pharmaceuticals Limited v.Ridley Life Science Pvt. Ltd.
The Delhi High Court dismissed the defendant's attempt to reopen evidence regarding costs and damages in a trademark infringement suit. The court noted the defendant's history of 'abysmal conduct,' including being a 'habitual offender/rank infringer' who repeatedly infringes third-party products. Given that the defendant had ample opportunity to present their case previously, the court found the late application was not bona fide and aimed only at delay.
Mankind Pharma Limited v.Manking Pharmaceutical Private Limited & Anr.
The Delhi High Court granted an ex parte ad interim injunction in favor of Mankind Pharma Limited against Manking Pharmaceutical Private Limited. The court found a prima facie case based on the phonetic similarity between the 'MANKIND' mark and the defendant's adopted variations, as well as the use of a deceptively similar logo device. Furthermore, the plaintiff highlighted suspicious corporate links, suggesting the defendant was incorporated by an ex-employee to dishonestly adopt the protected brand identity.
Mankind Pharma Limited v.Solitaire Pharmacia And Anr
The Delhi High Court issued an order in the trademark dispute between Mankind Pharma Limited and Solitaire Pharmacia And Anr. The court directed the Respondent to file additional documents demonstrating that the Petitioner was simultaneously seeking rectification of the impugned trademark 'CUREKIND' before the Trademark Registry. Furthermore, the hearing was adjourned to September 2nd, 2024, allowing both parties time to submit composite briefs.
Jaypee Brothers Medical Publisher Pvt Ltd v.Rama Krishna Books
The Delhi High Court granted an ex parte ad interim injunction in favor of Jaypee Brothers Medical Publisher Pvt Ltd against Rama Krishna Books. The publisher alleged that the defendant was selling substandard, infringing copies of their medical textbooks while also misusing their registered trademarks. The court found a prima facie case for infringement and ruled that granting the injunction was necessary to prevent irreparable harm to the plaintiff's business interests in the specialized medical publishing market.
Sun Pharma Laboratories Limited v.Narender Kumar & Ors.
The Delhi High Court upheld the existing interim injunction in favor of Sun Pharma Laboratories Limited against Narender Kumar & Ors. The dispute centered on alleged passing off, where the defendant used the mark 'CAFTADAY' for an eye drop containing the compound ALCAFTADINE, deceptively similar to the plaintiff's mark 'CAFTA'. Despite arguments from the defense regarding generic drug naming conventions and INNs, the Court found that the plaintiff had satisfied the triple test for passing off. Consequently, the injunction was maintained, preventing the defendants from using the impugned mark during the pendency of the suit.
Novartis Ag & Ors. v.Noviets Pharma & Ors.
The Delhi High Court addressed several interlocutory applications in the trademark infringement dispute between Novartis Ag & Ors. and Noviets Pharma & Ors. The court allowed the plaintiffs to file additional documents and granted an exemption from mandatory pre-suit mediation. Crucially, the court formally registered the plaint as a suit, setting out detailed procedural timelines for filing written statements, replications, and affidavits of admission/denial, while also addressing the preliminary injunction application seeking restraint against trademark infringement.
M/s.Mesmer Pharmaceuticals v.The Registrar of Trade Marks
The Madras High Court set aside the Trade Marks Registry's decision to refuse registration of 'REJUSTAR' in Class 5. The Registrar had cited phonetic similarity to other marks, but the court held that it was premature to determine deceptive similarity based solely on scrutiny under Section 11. Given that the appellant's mark is an invented word and the cited marks were used for different goods or outside India, the matter was remanded back to the Registry for further processing.
Rexcin Pharmaceuticals P Ltd v.Rekin Pharma P Ltd & Anr.
The Delhi High Court addressed a complex trademark dispute between Rexcin Pharmaceuticals and Rekin Pharma concerning the similar corporate names 'REXCIN' and 'REKIN'. The court noted that while Rexcin holds registrations for 'REXCIN', they are not currently using it commercially, whereas Rekin has registered 'REKIN-SP' in Class 05. To resolve the conflict, the Court proposed a potential settlement where both parties could agree to restrict the use of the disputed term only as part of their corporate name, rather than as a trademark or trade name. Both counsels agreed to consult their clients on this proposal and were directed to consider mediation.
Wings Pharmaceuticals P. Ltd. v.Khatri Healthcare P. Ltd. & Anr.
The Delhi High Court clarified its earlier order in this trademark cancellation petition. The Petitioner, Wings Pharmaceuticals P. Ltd., sought clarification after raising objections regarding territorial jurisdiction. Consequently, the court allowed the application, permitting the Petitioner to withdraw the current case and file a fresh petition before the appropriate Trademark Registry in Mumbai. Crucially, the court emphasized that this withdrawal does not prejudice the parties' rights or express any view on the merits of the original dispute.
Antex Pharma Pvt Ltd & Anr. v.Elder Projects Ltd & Anr.
The Delhi High Court granted an interim injunction in favor of Antex Pharma Pvt Ltd, restraining Elder Projects Ltd and its representatives from issuing baseless threats of legal action against the plaintiffs concerning the use of the trademark 'ELDER' and 'ELDERVIT'. The court relied heavily on a prior judgment establishing that the registered ownership of the 'ELDER' mark belongs to Elder Pharmaceuticals Limited (EPL), which is currently in liquidation. This ruling protects the plaintiffs from harassment while maintaining that the interim order does not grant them absolute entitlement to use the trademark.
Indchemie Health Specialities Pvt. Ltd. v.M/s.Orchid Chemicals & Pharmaceuticals Limited
The Madras High Court allowed an appeal filed by Indchemie Health Specialities Pvt. Ltd., setting aside a previous rejection by the Trade Marks Registry. The core issue was the similarity between the appellant's registered word mark 'ORKID' and the respondent's applied-for word mark 'ORZID' in Class 5 (pharmaceutical products). The Court found that despite minor spelling differences, the marks were visually similar and capable of causing confusion, thereby directing the rectification of the trademark register.
Sun Pharma Laboratories Ltd. v.The Registrar of Trade Marks
The Madras High Court ruled in favor of Sun Pharma Laboratories, setting aside an order by the Trade Mark Registry that had declared its opposition to a rival mark ('LIBOSE') as abandoned. The core issue was whether the Registry properly served the counter statement to the appellant. The court held that since the Registry failed to provide concrete proof of service—relying only on a website notification—the principle of natural justice was violated, necessitating the remand of the matter.
Dr Reddys Laboratories Limited v.Dr Reddys Pathlabs Private Limited
The Delhi High Court found that Dr Reddys Pathlabs Private Limited was in prima facie contempt of a previous court order by expanding its operations under the 'DR. REDDY'S' mark, even if those new centers were directly owned rather than franchised. The Court ruled that the original undertaking to maintain status quo was intended to prevent any proliferation of business under the contested mark, regardless of ownership structure. Consequently, the Defendant was served with a show cause notice regarding contempt.
Glenmark Pharmaceuticals Ltd. v.Mylan Laboratories Limited
The Madras High Court ruled in favor of Glenmark Pharmaceuticals, allowing its appeal against the Trade Mark Registry's rejection of its opposition. The core issue was the strict adherence to timelines regarding evidence submission. The court held that while deadlines are necessary for discipline, they should not extinguish a party's substantial rights, especially when those rights face imminent threat from registration. Consequently, the opposition has been restored and the matter is directed to be disposed of according to law.
Nectar Biopharma Private Limited v.M/S. Kashmik Formulations Private Limited
In this trademark infringement matter, the Delhi High Court allowed the Plaintiff's application seeking to implead Mr. Nilesh M. Patel, Director of Defendant No. 1. The court found that since Mr. Patel was the proprietor of M/s Nectar Lifecare and his marks were applied for registration, he was a necessary party due to the exclusive supply relationship between Defendant No. 1 and M/s Nectar Lifecare. This decision significantly expands the scope of the litigation by bringing in an individual directly connected to the disputed intellectual property rights.
The Himalaya Durg Company & Ors v.Himalya International Ltd
In this ongoing trademark infringement suit, the Delhi High Court addressed an application by the defendant seeking permission to file fresh evidence. Despite objections from the plaintiffs that the new defense went beyond pleadings, the court permitted the filing of the affidavit in evidence (DW-1). The court also reminded both parties about the long pendency of the case and directed a day-to-day trial to expedite proceedings.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.